On T lymphocytes, DNAM-1+ cells had higher expression of PD-1, CD39, CD127, and LAG-3; immune exhaustion markers previously associated with poor HCC outcome [38,39,40]; and higher CD69, a cytotoxicity marker. The gene discussed is ENTPD1; the disease is hepatocellular carcinoma.